{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:56:58Z","timestamp":1793044618531,"version":"4.5.0"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:p>\n                    Tramadol is a unique analgesic medication, available in variety of formulations, with both monoaminergic reuptake inhibitory and opioid receptor agonist activity increasingly prescribed worldwide as an alternative for high-affinity opioid medication in the treatment of acute and chronic pain. It is a prodrug that is metabolized by cytochrome P450 (CYP) enzymes CYP2D6 and CYP3A4 to its more potent opioid analgesic metabolites, particularly the\n                    <jats:italic toggle=\"yes\">O<\/jats:italic>\n                    -demethylation product M1. The opioid analgesic potency of a given dose of tramadol is influenced by an individual\u2019s CYP genetics, with poor metabolizers experiencing little conversion to the active M1 opioid metabolite and individuals with a high metabolic profile, or ultra-metabolizers, experiencing the greatest opioid analgesic effects. The importance of the CYP metabolism has led to the adoption of computer clinical decision support with pharmacogenomics tools guiding tramadol treatment in major medical centers. Tramadol\u2019s simultaneous opioid agonist action and serotonin (5-HT) and norepinephrine reuptake inhibitory effects result in a unique side effect profile and important drug interactions that must be considered. Abrupt cessation of tramadol increases the risk for both opioid and serotonin\u2013norepinephrine reuptake inhibitor withdrawal syndromes. This review provides updated important information on the pharmacology, pharmacokinetics, CYP genetic polymorphisms, drug interactions, toxicity, withdrawal, and illicit use of tramadol.\n                  <\/jats:p>","DOI":"10.1213\/ane.0000000000001683","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T19:53:12Z","timestamp":1479412392000},"page":"44-51","source":"Crossref","is-referenced-by-count":304,"title":["Trends in Tramadol: Pharmacology, Metabolism, and Misuse"],"prefix":"10.1213","volume":"124","author":[{"given":"Karen","family":"Miotto","sequence":"first","affiliation":[{"name":"Vermont Center for Behavior and Health, Department of Psychiatry, University of Vermont, Burlington, Vermont."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur K.","family":"Cho","sequence":"additional","affiliation":[{"name":"Vermont Center for Behavior and Health, Department of Psychiatry, University of Vermont, Burlington, Vermont."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Khalil","sequence":"additional","affiliation":[{"name":"Vermont Center for Behavior and Health, Department of Psychiatry, University of Vermont, Burlington, Vermont."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Blanco","sequence":"additional","affiliation":[{"name":"Vermont Center for Behavior and Health, Department of Psychiatry, University of Vermont, Burlington, Vermont."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun D.","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Vermont Center for Behavior and Health, Department of Psychiatry, University of Vermont, Burlington, Vermont."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Rawson","sequence":"additional","affiliation":[{"name":"Vermont Center for Behavior and Health, Department of Psychiatry, University of Vermont, Burlington, Vermont."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230812","first-page":"CD003726","article-title":"Tramadol for neuropathic pain","volume":"3","author":"Duehmke","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R2-20230812","first-page":"CD005522","article-title":"Tramadol for osteoarthritis.","volume":"3","author":"Cepeda","year":"2006","journal-title":"The Cochrane Library"},{"key":"R3-20230812","first-page":"CD004959","article-title":"Opioids compared to placebo or other treatments for chronic low-back pain","volume":"8","author":"Chaparro","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-20230812","article-title":"Opioid therapy for treating rheumatoid arthritis pain.","volume":"11","author":"Whittle","year":"2011","journal-title":"The Cochrane Library"},{"key":"R5-20230812","first-page":"1964","article-title":"Tramadol for acute pain: a review of the evidence.","volume":"72","author":"Sonis","year":"2005","journal-title":"Am Fam Physician"},{"key":"R6-20230812","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.curtheres.2008.02.006","article-title":"Pharmacokinetics and postoperative analgesia of epidural tramadol: a prospective, pilot study.","volume":"69","author":"Kubota","year":"2008","journal-title":"Curr Ther Res Clin Exp"},{"key":"R7-20230812","first-page":"913","article-title":"Oral analgesics for acute nonspecific pain.","volume":"71","author":"Sachs","year":"2005","journal-title":"Am Fam Physician"},{"key":"R8-20230812","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ijir.2015.7","article-title":"Tramadol for the management of premature ejaculation: a timely systematic review.","volume":"27","author":"Kirby","year":"2015","journal-title":"Int J Impot Res"},{"key":"R9-20230812","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2490-15-6","article-title":"Tramadol for premature ejaculation: a systematic review and meta-analysis.","volume":"15","author":"Martyn-St James","year":"2015","journal-title":"BMC Urology"},{"key":"R10-20230812","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.XHA.0000399371.38752.73","article-title":"Comparative study between tramadol (50 mg) on demand and paroxitine HCl (20 mg) on demand in the treatment of premature ejaculation.","volume":"1","author":"Eid","year":"2011","journal-title":"Human Andrology"},{"key":"R11-20230812","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical pharmacology of tramadol.","volume":"43","author":"Grond","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"R12-20230812","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/bja\/aer126","article-title":"An update on analgesics.","volume":"107","author":"Power","year":"2011","journal-title":"Br J Anaesth"},{"key":"R13-20230812","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States.","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"key":"R14-20230812","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0022-3565(25)39454-1","article-title":"Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.","volume":"267","author":"Raffa","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"R15-20230812","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/appi.psy.50.2.169","article-title":"Pharmacokinetic drug interactions of synthetic opiate analgesics.","volume":"50","author":"Armstrong","year":"2009","journal-title":"Psychosomatics"},{"key":"R16-20230812","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"R17-20230812","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/JCP.0b013e318160f827","article-title":"Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol.","volume":"28","author":"Kirchheiner","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R18-20230812","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1213\/ANE.0b013e31821d01bc","article-title":"CYP2D6- and CYP3A-dependent enantioselective plasma concentrations of ondansetron in postanesthesia care.","volume":"113","author":"Stamer","year":"2011","journal-title":"Anesth Analg"},{"key":"R19-20230812","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/chir.10316","article-title":"Pharmacokinetics of the enantiomers of trans-tramadol and its active metabolite, trans-O-demethyltramadol, in healthy male and female Chinese volunteers.","volume":"16","author":"Hui-Chen","year":"2004","journal-title":"Chirality"},{"key":"R20-20230812","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2165\/11635500-000000000-00000","article-title":"Analgesics in patients with hepatic impairment: pharmacology and clinical implications.","volume":"72","author":"Bosilkovska","year":"2012","journal-title":"Drugs"},{"key":"R21-20230812","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/0269216311406313","article-title":"A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project.","volume":"25","author":"King","year":"2011","journal-title":"Palliat Med"},{"key":"R22-20230812","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s40266-015-0315-4","article-title":"Pharmacokinetics of tramadol and O-desmethyltramadol enantiomers following administration of extended-release tablets to elderly and young subjects.","volume":"32","author":"Skinner-Robertson","year":"2015","journal-title":"Drugs Aging"},{"key":"R23-20230812","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0929-6646(09)60260-6","article-title":"Catatonia associated with coadministration of tramadol and meperidine","volume":"106","author":"Huang","year":"2007","journal-title":"J Formos Med Assoc"},{"key":"R24-20230812","first-page":"309","article-title":"Complex hallucination (visual-auditory) during coadministration of tramadol and clarithromycin.","volume":"12","author":"Kov\u00e1cs","year":"2010","journal-title":"Neuropsychopharmacol Hung"},{"key":"R25-20230812","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00228-012-1460-x","article-title":"Rifampicin markedly decreases the exposure to oral and intravenous tramadol.","volume":"69","author":"Saarikoski","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"R26-20230812","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.tpj.6500285","article-title":"Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.","volume":"5","author":"Ingelman-Sundberg","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"R27-20230812","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.clpt.6100152","article-title":"Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.","volume":"82","author":"Stamer","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R28-20230812","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.tpj.6500406","article-title":"Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.","volume":"7","author":"Kirchheiner","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"R29-20230812","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0019-5049.108584","article-title":"Addiction and seizure ability of tramadol in high-risk patients.","volume":"57","author":"Mehrpour","year":"2013","journal-title":"Indian J Anaesth"},{"key":"R30-20230812","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1213\/ane.0b013e31817b796e","article-title":"Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication.","volume":"107","author":"Stamer","year":"2008","journal-title":"Anesth Analg"},{"key":"R31-20230812","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003495-200666020-00006","article-title":"Tramadol sustained-release capsules.","volume":"66","author":"Keating","year":"2006","journal-title":"Drugs"},{"key":"R32-20230812","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1634\/theoncologist.11-2-126","article-title":"Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications.","volume":"11","author":"Bernard","year":"2006","journal-title":"Oncologist"},{"key":"R33-20230812","first-page":"1553","article-title":"Ondansetron inhibits the analgesic effects of tramadol: a possible 5-HT(3) spinal receptor involvement in acute pain in humans.","volume":"94","author":"Arcioni","year":"2002","journal-title":"Anesth Analg"},{"key":"R34-20230812","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/00000539-200105000-00045","article-title":"The analgesic efficacy of tramadol is impaired by concurrent administration of ondansetron.","volume":"92","author":"De Witte","year":"2001","journal-title":"Anesth Analg"},{"key":"R35-20230812","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.1365-2044.1999.00714.x","article-title":"The use of tramadol following day\u2014case oral surgery.","volume":"54","author":"Broome","year":"1999","journal-title":"Anaesthesia"},{"key":"R36-20230812","first-page":"36","article-title":"Effect of ondansetron in lower extremity bone surgery on morphine and tramadol consumption using patient controlled analgesia.","volume":"19","author":"Cubuk\u00e7u","year":"2007","journal-title":"Agri"},{"key":"R37-20230812","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/anae.12948","article-title":"The effect of ondansetron on the efficacy of postoperative tramadol: a systematic review and meta-analysis of a drug interaction.","volume":"70","author":"Stevens","year":"2015","journal-title":"Anaesthesia"},{"key":"R38-20230812","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/anae.12972","article-title":"Tramadol\u2014the Marmite(\u2122) drug.","volume":"70","author":"Gibbison","year":"2015","journal-title":"Anaesthesia"},{"key":"R39-20230812","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jpain.2010.03.003","article-title":"Antagonistic effects of ondansetron and tramadol? A randomized placebo and active drug controlled study.","volume":"11","author":"Rauers","year":"2010","journal-title":"J Pain"},{"key":"R40-20230812","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1366-0071(03)00024-X","article-title":"Aspects of tramadol and ondansetron interactions.","volume":"5","author":"Hammonds","year":"2003","journal-title":"Acute Pain"},{"key":"R41-20230812","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome.","volume":"352","author":"Boyer","year":"2005","journal-title":"N Engl J Med"},{"key":"R42-20230812","first-page":"17","article-title":"Tramadol: seizures, serotonin syndrome, and coadministered antidepressants.","volume":"6","author":"Sansone","year":"2009","journal-title":"Psychiatry (Edgmont)"},{"key":"R43-20230812","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0897190013504957","article-title":"Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants?","volume":"27","author":"Park","year":"2014","journal-title":"J Pharm Pract"},{"key":"R44-20230812","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/106002809703100208","article-title":"Possible serotonin syndrome associated with tramadol and sertraline coadministration.","volume":"31","author":"Mason","year":"1997","journal-title":"Ann Pharmacother"},{"key":"R45-20230812","first-page":"309","article-title":"Possible serotonergic syndrome caused by combination of tramadol and sertraline in an elderly woman.","volume":"57","author":"Sauget","year":"2002","journal-title":"Therapie"},{"key":"R46-20230812","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1176\/appi.psy.47.1.8","article-title":"Psychotropic drugs and the perioperative period: a proposal for a guideline in elective surgery.","volume":"47","author":"Huyse","year":"2006","journal-title":"Psychosomatics"},{"key":"R47-20230812","doi-asserted-by":"crossref","first-page":"562","DOI":"10.12659\/AJCR.892264","article-title":"Transient serotonin syndrome caused by concurrent use of tramadol and selective serotonin reuptake inhibitor.","volume":"15","author":"Shakoor","year":"2014","journal-title":"Am J Case Rep"},{"key":"R48-20230812","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004714-200208000-00022","article-title":"Serotonin syndrome as a result of fluoxetine in a patient with tramadol abuse: plasma level-correlated symptomatology.","volume":"22","author":"Lange-Asschenfeldt","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"R49-20230812","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1176\/appi.ajp.161.6.1129","article-title":"Serotonin syndrome with tramadol and citalopram.","volume":"161","author":"Mahlberg","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R50-20230812","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1345\/aph.1Q748","article-title":"Avoiding serotonin syndrome: the nature of the interaction between tramadol and selective serotonin reuptake inhibitors.","volume":"46","author":"Nelson","year":"2012","journal-title":"Ann Pharmacother"},{"key":"R51-20230812","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1177\/1060028015604631","article-title":"Comparative toxicity of tapentadol and tramadol utilizing data reported to the national poison data system.","volume":"49","author":"Tsutaoka","year":"2015","journal-title":"Ann Pharmacother"},{"key":"R52-20230812","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/15563650.2015.1102927","article-title":"2014 annual report of the american association of poison control centers\u2019 national poison data system (NPDS): 32nd annual report.","volume":"53","author":"Mowry","year":"2015","journal-title":"Clin Toxicol (Phila)"},{"key":"R53-20230812","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s13181-011-0168-0","article-title":"Factors related to seizure in tramadol poisoning and its blood concentration.","volume":"7","author":"Taghaddosinejad","year":"2011","journal-title":"J Med Toxicol"},{"key":"R54-20230812","first-page":"484","article-title":"Tramadol induced seizure: a 3-year study.","volume":"3","author":"Boostani","year":"2012","journal-title":"Caspian J Intern Med"},{"key":"R55-20230812","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/1556365050014418","article-title":"Seizures associated with intoxication and abuse of tramadol.","volume":"44","author":"Jovanovi\u0107-Cupi\u0107","year":"2006","journal-title":"Clin Toxicol (Phila)"},{"key":"R56-20230812","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00000433-200012000-00015","article-title":"Lethal combination of tramadol and multiple drugs affecting serotonin.","volume":"21","author":"Ripple","year":"2000","journal-title":"Am J Forensic Med Pathol"},{"key":"R57-20230812","first-page":"PCC.09100779","article-title":"Tramadol dependence in a patient with no previous substance history.","volume":"12","author":"Ojha","year":"2010","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"R58-20230812","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.drugalcdep.2012.09.018","article-title":"Abuse liability and reinforcing efficacy of oral tramadol in humans.","volume":"129","author":"Babalonis","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"R59-20230812","doi-asserted-by":"crossref","first-page":"283425","DOI":"10.1155\/2013\/283425","article-title":"The investigation of tramadol dependence with no history of substance abuse: a cross-sectional survey of spontaneously reported cases in Guangzhou city, China","volume":"2013","author":"Zhang","year":"2013","journal-title":"Biomed Res Int"},{"key":"R60-20230812","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000353971","article-title":"Tramadol abuse in a binge pattern in a young depressed woman.","volume":"20","author":"Ferrari","year":"2014","journal-title":"Eur Addict Res"},{"key":"R61-20230812","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/pds.1838","article-title":"Tramadol dependence: a survey of spontaneously reported cases in Sweden.","volume":"18","author":"Tj\u00e4derborn","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R62-20230812","first-page":"11","article-title":"Potential for tramadol abuse by patients visiting pharmacies in northern Iran.","volume":"5","author":"Zabihi","year":"2011","journal-title":"Subst Abuse"},{"key":"R63-20230812","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.drugalcdep.2005.05.007","article-title":"Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users.","volume":"80","author":"Zacny","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"R64-20230812","first-page":"1818","article-title":"Tramadol abuse and dependence among physicians.","volume":"292","author":"Skipper","year":"2004","journal-title":"JAMA"},{"key":"R65-20230812","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.clpt.2004.11.002","article-title":"Paroxetine, a cytochrome P450 2D6 inhibitor, diminishes the stereoselective O-demethylation and reduces the hypoalgesic effect of tramadol.","volume":"77","author":"Laugesen","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"R66-20230812","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1517\/14740338.7.5.587","article-title":"Drug-induced serotonin syndrome: a review.","volume":"7","author":"Sun-Edelstein","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"R67-20230812","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40122-014-0023-5","article-title":"A model-based meta-analysis to compare efficacy and tolerability of tramadol and tapentadol for the treatment of chronic non-malignant pain.","volume":"3","author":"Mercier","year":"2014","journal-title":"Pain Ther"},{"key":"R68-20230812","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0376-8716(02)00321-6","article-title":"Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur.","volume":"69","author":"Senay","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"R69-20230812","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/eujp.2000.0187","article-title":"Acute abstinence syndrome following abrupt cessation of long-term use of tramadol (Ultram): a case study.","volume":"4","author":"Freye","year":"2000","journal-title":"Eur J Pain"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201701000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:27:50Z","timestamp":1786112870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201701000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000001683","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}